Clinically, miR-375-3p and its targets LRP5 and β-catenin might be used as diagnostic biomarkers for osteoporosis, osteoarthritis or osteosarcoma because they regulate or disturb osteogenesis. This evidence concerns the gene LRP5 and osteoarthritis.